依前列醇
依前列醇用途
为原发性肺动脉高血压治疗药。该品具有抗血小板和舒张血管作用,故可防止血栓形成。
依前列醇名称
[ CAS 号 ]:
35121-78-9
[ 中文名 ]:
依前列醇
[ 英文名 ]:
Epoprostenol
[中文别名 ]:
[英文别名 ]:
- PGX
- Epoprostenol
- MFCD00135629
- Prostaglandin l2
- prostacyclin
- Vasocyclin
- PGl2
- ProstaglandinI
- PGX(prostaglandin)
- Cyclo-Prostin
依前列醇生物活性
[ 描述 ]:
[ 相关类别 ]:
[ 靶点 ]
Human Endogenous Metabolite
[参考文献]
依前列醇物理化学性质
[ 密度 ]:
1.221g/cm3
[ 沸点 ]:
530.2ºC at 760mmHg
[ 分子式 ]:
C20H31NaO5
[ 分子量 ]:
374.44700
[ 闪点 ]:
182.1ºC
[ 精确质量 ]:
374.20700
[ PSA ]:
89.82000
[ LogP ]:
2.07380
[ 折射率 ]:
1.611
依前列醇毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- UK8008500
- CHEMICAL NAME :
- Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9-alpha,11-alpha,13E,15S)-
- CAS REGISTRY NUMBER :
- 35121-78-9
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C20-H32-O5
- MOLECULAR WEIGHT :
- 352.52
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 5 mg/kg
- SEX/DURATION :
- female 15-19 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - other effects Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
- REFERENCE :
- GOBIDS Gynecologic and Obstetric Investigation. (S. Karger Pub., Inc., 79 Fifth Ave., New York, NY 10003) V.9- 1978- Volume(issue)/page/year: 33,193,1992
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intravenous
- DOSE :
- 800 ng/kg
- SEX/DURATION :
- female 1-4 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - menstrual cycle changes or disorders Reproductive - Fertility - female fertility index (e.g. # females pregnant per # sperm positive females; # females pregnant per # females mated) Reproductive - Maternal Effects - other effects
- REFERENCE :
- JRPFA4 Journal of Reproduction and Fertility. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1960- Volume(issue)/page/year: 94,279,1992
依前列醇安全信息
[ 危害码 (欧洲) ]:
Xn
[ 风险声明 (欧洲) ]:
R20/21/22
[ 安全声明 (欧洲) ]:
S22;S26;S36
依前列醇合成路线
依前列醇制备
9,11,15-三羟基前列-5,13-二烯-1-酸经醚化,再和N-溴代丁二酰亚胺于四氢呋喃-氯仿的混合溶剂中反应,产品经水解,消除溴化氢,得到依前列醇。
相关化工产品/化学物质:
相关药品:
推荐生产厂家/供应商:
暂无推荐供应商。请联系客服获知如何成为推荐供应商。
相关化合物
【依前列醇】化源网提供依前列醇CAS号35121-78-9,依前列醇MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询依前列醇上化源网,专业又轻松。>>电脑版:依前列醇
标题:依前列醇_用途_密度_沸点_依前列醇CAS号【35121-78-9】_化源网 地址:https://www.chemsrc.com/amp/cas/35121-78-9_330317.html